Jump to content
Powered by
The Baden-Württemberg healthcare industry

The pharmaceutical industry

Baden-Württemberg is Germany’s largest pharma location. In addition to industry giants such as Roche, GlaxoSmithKline and Boehringer Ingelheim, Baden-Württemberg is home to a large number of small- and medium-sized pharmaceutical companies and biotech companies with pharmaceutical R&D. According to the Baden-Württemberg Ministry of Economics, Labour and Housing, Baden-Württemberg is Europe's leading location for producing and distributing medicines for special therapies such as homeopathy as well as herbal ingredients.

The pharmaceutical industry continues to be a recession-proof employer and is very loyal to Baden-Württemberg. According to BIOPRO 127 pharmaceutical companies are located in Baden-Württemberg. Of them, 40 companies are pure distributors or suppliers. 87 of the 127 pharmaceutical companies carry out research, development and/or manufacture in Baden-Württemberg. The Baden-Württemberg Statistics Office has been able to acquire key figures for 2017 for 84 out of the 87 companies:

  • The companies had 20,687 employees and generated taxable revenues of 7.1 billion euros
  • 66 companies (78%) had less than 250 employees.
  • 67% of revenue (4.8 billion euros) were generated by the 18 companies with more than 250 employees.
  • Most pharmaceutical companies are located in the southern Upper Rhine and Hochrhein-Bodensee regions (15 each) and the central Upper Rhine region (14).

  • Danube-Iller and Rhine-Neckar are the two regions with the highest revenues. Companies in the Donau-Iller region generated 30% of overall revenues and companies in the Rhine-Neckar region 17%.

Biotechnology is an important driver of innovation in the pharmaceutical industry. According to surveys by BIOPRO Baden-Württemberg, a total of 256 Baden-Württemberg companies are active in research, development and/or production in the region’s biotechnology and/or pharmaceutical industries. In 2017, 40,157 employees generated 11.2 billion euros in taxable revenues.

Phytopharmaceuticals 25%, Homeopathy 23%, Classical pharmaceuticals 22%, Contract production 15%, Contract research/deveolpment 14%, Generic drugs 9%
Fields of activity of pharmaceutical companies in Baden-Württemberg on the basis of data held in the BIOPRO company database (companies may have several fields of activity) © BIOPRO Baden-Württemberg GmbH
Website address: https://www.gesundheitsindustrie-bw.de/en/location/pharma